Wendy Carruthers - 15 Nov 2023 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role
EVP, Human Resources
Signature
/s/ Susan Thompson, Attorney-in-Fact
Issuer symbol
BSX
Transactions as of
15 Nov 2023
Net transactions value
-$537,316
Form type
4
Filing time
16 Nov 2023, 16:16:12 UTC
Previous filing
17 Oct 2023
Next filing
18 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSX Common Stock Options Exercise $56,237 +3,448 +6.7% $16.31 55,243 15 Nov 2023 Direct F1
transaction BSX Common Stock Options Exercise $38,717 +2,960 +5.4% $13.08 58,203 15 Nov 2023 Direct F1
transaction BSX Common Stock Sale $632,269 -11,671 -20% $54.17 46,532 15 Nov 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSX Stock Option (Right to Buy) Options Exercise $0 -3,448 -50% $0.000000 3,450 15 Nov 2023 Common Stock 3,448 $16.31 Direct F1, F3
transaction BSX Stock Option (Right to Buy) Options Exercise $0 -2,960 -50% $0.000000 2,959 15 Nov 2023 Common Stock 2,960 $13.08 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 9, 2023, intended to comply with the prior version of Rule 10b5-1(c).
F2 Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $53.89 to $54.41, inclusive. The reporting person undertakes to provide upon request by the U.S.Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3 Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant.
F4 Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant.